Further studies regarding the mechanistic differences between PPARγ stimulation of Aβ- and tau-related microglial activation will provide novel insights into the pathomechanisms of neurodegenerative diseases and possible new treatment strategies. This evidence concerns the gene MAPT and neurodegenerative disease.